Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carbosorb is an adsorbent medicinal product containing activated charcoal (carbo activatus) as its active ingredient. Developed and manufactured by the Slovak company Imuna Pharm, it is used to treat various gastrointestinal conditions including acute diarrhea, food poisoning, irritable bowel syndrome, and gastritis. It functions through physical adsorption, binding to toxins, gases, and pathogenic microorganisms in the digestive tract to prevent their systemic absorption. Carbosorb is available in tablet and oral powder forms and is indicated for adults and children aged three and older. It is classified under the ATC code A07BA51 as an adsorbent and digestive.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carbosorb.